Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Treasury Shares (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Treasury Shares for 15 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 49.03% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 49.03% increase, with the full-year FY2025 number at $1.7 million, up 49.03% from a year prior.
  • Treasury Shares was $1.7 million for Q4 2025 at Acadia Healthcare Company, down from $1.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.8 million in Q3 2025 to a low of $104000.0 in Q2 2025.
  • A 5-year average of $834642.8 and a median of $954514.5 in 2021 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: tumbled 77.61% in 2023, then skyrocketed 240.87% in 2024.
  • Acadia Healthcare Company's Treasury Shares stood at $926627.0 in 2021, then increased by 12.8% to $1.0 million in 2022, then plummeted by 67.85% to $336031.0 in 2023, then surged by 240.87% to $1.1 million in 2024, then skyrocketed by 49.03% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Treasury Shares are $1.7 million (Q4 2025), $1.8 million (Q3 2025), and $104000.0 (Q2 2025).